We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

MicroStrategy Incorporated (NASDAQ:MSTR) is one of the most oversold NASDAQ stocks to invest in. MicroStrategy Incorporated (NASDAQ:MSTR) provided an update on its Bitcoin holdings in a regulatory ...

MicroStrategy (MSTR) fell 62.5% year-over-year despite holding 713,502 bitcoins at 10% above its $76,052 cost basis. MicroStrategy reported a $17.44B unrealized loss in Q4 due to fair value accounting ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...

Evernorth holds 388 million XRP tokens purchased at an average price of $2.44, making it the largest institutional XRP holder. The company plans to list on Nasdaq under ticker XRPN in Q1 2026 through ...

Evernorth is about to become the MicroStrategy of XRP (CRYPTO: XRP). With 388 million tokens locked ahead of its Nasdaq debut under ticker XRPN, the company is building a public treasury that lets ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

A new malicious campaign mixes the ClickFix method with fake CAPTCHA and a signed Microsoft Application Virtualization (App-V) script to ultimately deliver the Amatera infostealing malware. The ...

Many investors keep a close eye on insider transactions, particularly buys, as they can often give a decent outlook surrounding the long-term picture. Of course, it’s important to note that insiders ...